Cell Medica announces the appointment of Kevin Boyle as Chief Financial Officer to head up the Company’s international financial activities
Kevin has over 20 years of diversified finance experience helping companies define and achieve strategic financial objectives. He has broad international experience with both public and private companies and has raised over $2.0 billion in capital over his career.
Before joining Cell Medica, Kevin served as Chief Financial Officer of FloWorks International and had held previous senior finance roles at Sigma Cubed, RecoverCare and SPT. Kevin graduated from Carnegie Mellon University with a B.S. in Industrial Management, and earned his J.D. from the University of Pennsylvania. He is active in the Houston community, serving as Treasurer of The Center for Hearing and Speech and on the Advisory Board of the Hermann Park Conservancy.
Kevin Boyle, Cell Medica’s Chief Financial Officer, added:
“I am excited to join the Cell Medica team as it is poised to enter the clinical phase with new technologies for treating cancer. I look forward to helping the company achieve its goals by accessing the capital markets to fund a robust R&D pipeline.”